Antigen:
Cytokeratin 14/17
Classification:
Polyclonal
Gene Alias:
39.1; AI626930; CK14; CK-14; CK-17; cytokeratin 14; cytokeratin-14; Cytokeratin-17; EBS3; EBS4; epidermolysis bullosa simplex, Dowling-Meara, Koebner; K14; K17; Ka14; Ka17; keratin 14; keratin 14 (epidermolysis bullosa simplex, Dowling-Meara, Koebner); keratin 14, type I; keratin 17; keratin 17, type I; keratin complex 1, acidic, gene 14; keratin complex 1, acidic, gene 17; keratin, type I cytoskeletal 14; Keratin, type I cytoskeletal 17; keratin-14; Keratin-17; Krt-1.14; Krt1-14; Krt1-17; KRT14; KRT17; krt17 {ECO:0000250; LOC100737113; NFJ; PC; PC2; PCHC1; type I keratin Ka14; Type I keratin Ka17; UniProtKB:Q04695}
Purification Method:
affinity chromatography
Gene ID (Entrez):
16664, 16667, 287701, 287702, 3861, 3872
Content And Storage:
-20°C
Applications:
Immunohistochemistry (Paraffin), Western Blot
Formulation:
PBS with 0.5% BSA, 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.:
P02533, Q04695, Q61781, Q6IFU8, Q6IFV1, Q9QWL7
Gene Symbols:
KRT14, KRT17
Immunogen:
Synthesized peptide derived from human Cytokeratin 14/17 [aa 261-310].
Primary or Secondary:
Primary
Target Species:
Human, Mouse, Rat